Introduction
In the Corpus Hippocraticum on air in the year 400 BC, Hippocrates mentioned tracheal intubation as a method of ventilating the lungs [1] . Since then, intubation, the endotracheal tube (ETT) itself, and the incorporation of mechanical ventilation have progressed enormously. Despite technological advances, mechanical ventilatorassociated pneumonia (VAP) continues to be a frequent and feared complication [2 ,3] . The pathogenesis of VAP is closely related to the presence of the ETT and some authors have even suggested that the name of the disease be changed to endotracheal tube-associated pneumonia [4, 5] . The insertion of the ETT is an aggressive maneuver that often produces lesions in the tracheal mucosa and the implantation of exogenous and endogenous bacterial inoculum [6] . The presence of the ETT annuls the cough reflex, leads to accumulation of secretions in the subglottic space and does not totally impede their entry into the lung, thereby making it an ideal surface for the formation of biofilm and a risk factor for the development of sinusitis [5] [6] [7] [8] [9] [10] [11] .
In this article we review all the aspects of the pathogenesis of VAP in relation to the ETT, which have been studied in an attempt to prevent the development of this type of pneumonia.
Subglottic secretions
The accumulation of secretions from the oropharynx or the gastrointestinal tract in the subglottic space may be demonstrated by radiography [7] or the quantification of the material obtained by local aspiration [12] . Endogenous or exogenous colonization of these secretions is practically unavoidable and the causal relationship with VAP has been well established [6, [12] [13] [14] [15] . Preventive measures aimed at avoiding VAP include impeding the leakage between the tube and the tracheal wall, and aspiration or sterilization of the secretions.
Control of cuff pressure
The maintenance of correct cuff pressure (P cuff ) is essential in patients receiving mechanical ventilation [6, 16, 17] . Excessive pressure may compromise the microcirculation of the tracheal mucosa and cause ischemic lesions [18, 19] , while insufficient P cuff impedes ventilation with positive pressure and may allow the entry of subglottic secretions between the tube and the trachea. Rello et al. [10] analyzed the effect that P cuff has on the development of VAP in the first 8 days of mechanical ventilation and demonstrated that a maintained P cuff greater than 20 cmH 2 O is associated with lower risk. Multivariate analysis, however, only showed that P cuff maintained at less than 20 cmH 2 O is an independent risk factor in the subgroup of patients without antibiotic treatment [10] .
This was the only study aimed at relating a determined P cuff value with the risk of developing VAP. Several studies have reported the leakage of secretions despite the maintenance of a correct P cuff and even at greater than the normal limits [20] [21] [22] but did not analyze whether this entry influenced the appearance of VAP. Neither have studies on methods to achieve better control of P cuff analyzed the effect of these maneuvers on VAP [23] [24] [25] , except in one case [26] in which better control of P cuff by an automatic system did not reduce the incidence of VAP.
Many studies have evaluated better techniques and their relationship with the aspiration of secretions beyond the endotracheal cuff. The leakage of secretions despite a correct P cuff has been explained by the formation of folds in the cuff allowing longitudinal leakage [20] [21] [22] . The elimination of these folds has been achieved with the use of lubricating gels (effective during 24-120 h) [27] , silicone pressure cuffs [28] , or the use of low-pressure cuffs [29 ] , yet it has not been proven whether these improvements have been accompanied by a lower incidence of VAP.
Therefore, although it is obvious that adequate healthcare intubation and mechanical ventilation must be accompanied by correct P cuff and that the leakage of secretions to the bronchial tree depends on the P cuff and its characteristics, there is scarce scientific evidence [10] justifying a close relationship between these elements and the appearance of VAP.
Subglottic secretions drainage
Based on the inefficacy of the P cuff in avoiding aspiration and on the considerable volume of secretions that accumulate in the subglottic space [7] , a new ETT was developed (HI-LO Evac tube; Mallinckrodt, Hazelwood, Missouri, USA). This new tube has an independent dorsal lumen, which makes it possible to aspirate the subglottic secretions.
Four randomized prospective studies have evaluated the effect intermittent or continuous aspiration of subglottic secretions (CASS) has on the appearance of VAP (Table 1) [12, 14, 15, 30] .
In all the studies the number of episodes of VAP were reduced but statistical significance was only achieved in two studies (accumulated incidence and rate of incidence per 1000 days of mechanical ventilation) [14, 15] .
With respect to the influence of subglottic secretions drainage (SSD) on the time of the appearance of VAP, three studies coincide in that SSD produces a delay in the development of VAP (all with statistical significance) [12, 15, 30] . A fourth study [14] distinguished between the influence of SSD on early and late onset VAP and observed that no changes were produced in the incidence of early VAP. This was attributed to early VAP being more related to the process of intubation.
Aspiration of subglottic secretions does not seem to have any effect on mortality, the duration of mechanical ventilation or intensive care unit (ICU) or hospital stay [14, 15, 30] .
The effect of SSD on the colonization of the subglottic space and the trachea has only been evaluated in one study [12] which found that SSD achieved a lower increase in the rate of contamination during ICU stay (þ6.6% versus þ21.2% in the trachea and þ2.1% versus þ33.4% in the subglottic space).
Aspiration of subglottic secretions does not affect all the microorganisms involved in pulmonary colonization/infection in the same way. The protective effect described by Valles and Smulders [14, 15, 30] is derived from a fall in the number of pneumonias caused by Grampositive germs. Mahul did not specify the etiology of the pneumonia based on the use or not of SSD, and in the study by Kollef, the number of pneumonias was too small for any conclusion to be drawn [12, 30] . The different effect on the microorganism may be secondary to the selection of late VAP or may be due, at least in part, to a direct action of SSD on the cause of infection. The SSD diminishes the quantity of microorganisms which reach the bronchial tree and since the inoculum necessary to cause VAP by Gram-positive cocci is much greater than that necessary in the case of Enterobacteriaceae or Pseudomonas aeruginosa [31, 32] , this quantitative effect may explain the differences observed. Another possible explanation is based on the fact that not all microorganisms follow the same pattern of airway colonization [33] [34] [35] [36] . P. aeruginosa and probably other nonfermenting Gram-negative bacteria seem to have a greater ability to adhere and colonize the tracheal epithelial cells than buccal or oropharyngeal cells [37] [38] [39] . In the studies 191 by Mahul et al. [12] and Valles et al. [15] , these authors found that there was no colonization prior to the subglottic secretions in a considerable proportion (40% and 16.6%, respectively) of the VAP produced by nonfermenting Gram-negative bacilli. If P. aeruginosa does not colonize or multiply in the subglottic area, the preventive measure of VAP affecting the subglottic secretions will not influence the pneumonia caused by this microorganism.
Rello et al. [10] also evaluated the effect of CASS on the risk of developing VAP. In a series of 83 patients receiving mechanical ventilation, they found that the failure of CASS was an independent risk factor for VAP (RR 5.29; 95% CI 1. 24-22.64 ).
In studies in humans no adverse effect of SSD has been detected even when establishing the safety of the device was one of the main objectives [30] . Berra et al. [40] , however, carried out a study of CASS in sheep and found diffuse lesions in the tracheal mucosa secondary to aspiration.
Aspiration of subglottic secretions is a preventive measure which, in clinical practice, does not seem to have severe adverse effects and has shown the capacity of diminishing the incidence of VAP, although the data available to date do not have sufficient statistical power.
Decontamination of subglottic secretions
Selective decontamination of the digestive tract (SDD), including topical antibiotic application in the oropharynx and the gastrointestinal tract, and the parenteral administration of antibiotics, is a controversial measure aimed at preventing nosocomial infections, and the results of the different studies are not concordant. The most recent meta-analysis [41, 42] indicates that SDD would be fundamentally effective in surgical or trauma patients probably due to the use of parenteral antibiotics, and not to topical application. On the other hand, there are abundant data indicating that SDD may promote the appearance of antibiotic resistance and, thus, its systematic use has not been recommended [2, 43] .
The belief, by some authors, of the lesser importance of the gastrointestinal tract as a source of VAP-producing microorganisms [35] particularly when fulfilling the recommendation of maintaining a semi-recumbent position in all patients receiving mechanical ventilation [44] , has led to the application of more local decontamination measures. Modulation of the bacterial flora of the oropharynx by topical antibiotics [45] [46] [47] [48] or antiseptics [49] has been effective in the prevention of VAP but its use has again been modified according to the possibility of the appearance of bacterial resistance. A new, more sophisticated version includes continuous infusion of the antibiotic solution in the subglottic space by the dorsal HI-LO lumen Mallinckrodt Evac tube with frequent oropharyngeal aspiration: 30 trauma patients were randomly assigned to receive this measure versus 31 controls. The authors described a lower incidence of VAP, the later appearance of VAP, and lower colonization of the bronchial tree [50] .
Decontamination in a more or less extensive region seems to have clear beneficial effects with respect to the control of nosocomial infections and may even influence the mortality. The probable effect that these maneuvers seem to have in the selection of microorganisms resistant to antibiotics, however, impedes their generalized use. The indication should be modified on the basis of the characteristics of the unit in which they are performed and the type of patient involved.
Biofilm
Biofilm is a complex structure made up of bacteria. Bacteria acquire a hypometabolic sessile form, and through the regulation by specific genes secrete a polymeric extracellular substance that makes them strongly adhere to each other and the chosen substrate. Biofilm has been widely studied by industrial microbiology and the findings have been applied to clinical microbiology [51] . The implication of biofilm in infections caused by the presence of artificial endocorporal devices has gained great importance in recent years [52] [53] [54] .
The nature of biofilm is viscous and adherent, making elimination difficult. Bacteria embedded in biofilm are protected by this mechanical effect, by the difficulty for antibiotics to penetrate and by having greater resistance to antibiotics. Antibiotic resistance is due to the hypometabolic state of the bacteria as well as a genetic regulation that is very close to that which modulates the formation of biofilm itself [55] . Pseudomonas spp. is the paradigm of bacteria that use biofilm as part of their pathogenic arsenal, and its presence in the biofilm has been related to recurrent VAP by this microorganism [56, 57] .
In 1986 Sottile et al. [58] were the first to detect the presence of biofilm in 25 ETTs used in critically ill patients; 84% were totally covered and 16% partially covered. Later, Inglis et al. [8] found biofilm in 100% of the tubes analyzed, including 17 that had been used for less than 24 h. Microbiologic analysis observed bacteria in 73% of the cases, mainly Pseudomonas spp. and Enterobacteriaceae. These authors simulated mechanical ventilation in vitro with the tubes analyzed and found that the bacteria were projected at least 15 cm with an elliptic distribution [8] .
As occurs with other infections potentially related to biofilm, it is difficult to establish a causal relationship.
The bacteria are found in the biofilm as are the causal agents of the infection but they do not always fulfill the postulations of Koch [59] . The correlation between the bacteria present in the biofilm and the etiology of the pneumonia has been analyzed by two authors. Feldman et al. [60] observed that in 13 patients with pneumonia, study of the biofilm of the ETT withdrawn demonstrated the same microorganism in eight cases. Adair et al. [61] observed this correlation in 70% of the patients with pneumonia and in none of the patients who did not develop this complication.
The implication of biofilm in the pathogenesis of VAP has not been completely clarified since it may be the source of the infection or may be a reservoir of potentially pathogenic bacteria [62] . Numerous studies, however, have been aimed at preventing, eliminating or decontaminating the biofilm.
Prevention of the formation of biofilm
In an in-vitro study, Jones et al. demonstrated that tubes covered in an antiseptic solution did not present the formation of biofilm [63, 64] . These results were also confirmed in vitro showing a lesser degree of colonization in tubes impregnated with chlorhexidine and silver carbonate (P < 0.01). Analysis of the ETT after 5 days demonstrated permanence of the antiseptic in 45% [65] .
The in-vivo study was performed in 16 sheep receiving mechanical ventilation. Fifty per cent of the tubes were covered with silver sulfadiazine and chlorhexidine. After 24 h the sheep were sacrificed and a greater presence of intensely colonized biofilm was observed in the ETT of the control group as was greater colonization of the circuit of the respirator (both data statistically significant). Tracheal colonization was greater, albeit not significantly, in the control group (P ¼ 0.119 and P ¼ 0.052 for the total number of tracheas colonized and for the degree of colonization, respectively). Colonization of the pulmonary parenchyma was statistically higher in the control group. The bacteria isolated were identical to those found in the oropharyngeal samples and ETT for each sheep [66] .
The use of biomaterial covered with silver for the prevention of nosocomial infections is a measure currently being studied in endovascular and urinary catheters, with demonstrated efficacy in the latter [67] . Olson et al. [68] studied the use of silver-coated ETT in five dogs versus six controls after the administration of a buccal inoculum of P. aeruginosa. After 96 h of mechanical ventilation, the group with the silver-coated ETT showed lower colonization of the ETT by aerobic bacteria (P ¼ 0.009) and by P. aeruginosa (P ¼ 0.076), lesser, albeit not statistically significant, tracheal and main bronchi colonization, and a lower colonization of the pulmonary parenchyma by
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The search for biomaterial and variations of the same to avoid the formation of biofilm is a promising field but has yet to prove its clinical efficacy. On the other hand, part of the economic costs which the commercialization of these devices may represent should be carefully evaluated.
Elimination of biofilm
Complete mechanical elimination of the mucus and biofilm adhered on the internal surface of the ETT is not possible with the usual aspiration tubes. A device capable of performing mechanical cleansing of the interior of the ETT has recently been designed: the mucus shaver. This device is a tube with an inflatable balloon with two rings on the end. Once the balloon has been inflated in the interior of the ETT, the rings obliterate the tube. The extraction of the tube eliminates all the adhered mucus. Kolobow et al. [69 ] tested this device in six sheep undergoing mechanical ventilation versus a control group made up of two other sheep. No technical problem or harmful effect was observed in the ventilatory mechanisms and each use of the mucus shaver obtained a mean of 0.35 AE 0.29 g of mucus. After 72 h, electron microscopy analysis of the ETT in the control group showed extensive biofilm formation while this was absent in the study group [69 ] . The same authors repeated the experience in 12 intubated sheep with ETT impregnated with a silver-sulfadizine solution. Six sheep were treated with the mucus shaver every 6 h. In contrast to the control group, no biofilm was found in the interior of the ETT in the study group after 72 h of mechanical ventilation [70 ] .
This novel system of ETT cleansing requires further larger clinical trials to corroborate its clinical efficacy and the absence of undesirable effects in critically ill patients receiving mechanical ventilation.
Decontamination of the biofilm
Since biofilm is formed by bacteria, their elimination would also mean the disappearance of the biofilm. Thus, the group of Adair et al. studied the effect of digestive decontamination (amphotericin B, tobramycin and polymyxin) on the biofilm and observed a reduction in colonization by enterobacteria but a persistence of the biofilm formed by Gram-positive bacilli and Pseudomonas spp. On the other hand, the concentration of the antibiotics used in the ETT was erratic and was often lower than the minimum inhibitory concentration necessary, particularly in the case of tobramycin [71, 72] .
This same work group compared the effect of biofilm on the use of parenteral cefotaxime and cefuroxime and gentamycin administered in aerosol. The characteristics of the patients were similar even with respect to the time of mechanical ventilation prior to the study of the ETT. The ETT of the 24 patients treated with parenteral cephalosporins developed biofilm in all the cases and in 62.5% potentially pathogenic microorganisms were found. The ETT of the 12 patients treated with aerosolized gentamycin developed biofilm in 41.6% of the cases but no pathogenic bacteria were isolated. The authors made sequential measurements of the concentration of the antibiotics in the interior of the ETT 2 h after each administration. The concentrations of the cephalosporins were insufficient to inhibit bacterial growth while gentamycin was able to maintain correct concentrations. With respect to the possible appearance of resistance after a 3-year period, only some strains of gentamycin-resistant Staphylococcus aureus have been reported [73] .
The use of gentamycin in aerosol may be useful in clinical practice although further studies are necessary to confirm these results. As with the maneuvers designed to treat the biofilm, systematic recommendation requires clinical trials to measure the impact on the incidence of VAP.
Early tracheostomy
Tracheostomy allows oral alimentation and communication and facilitates oral and bronchial cleansing [74] . This technique is not without risk, however, and, thus, its indication and timing should be carefully evaluated [75] . Studies evaluating the possible beneficial effects of early tracheostomy included a population with expected prolonged mechanical ventilation, mainly in patients with trauma or severe cerebral lesions. Several retrospective or non-randomized studies have evaluated early tracheostomy with varied results: a decrease in ICU stay [76 ,77] , a reduction in the duration of mechanical ventilation [76 ,77-79] , a decrease in the incidence of VAP [76 ,79] , a reduction in costs [78] and even an absence of beneficial effects [80] . The two reports including the aims of analyzing the effect of early tracheostomy on the incidence of VAP were retrospective and the criteria used to define pneumonia were not adequate [76 ,79] .
Five methodologically correct, prospective, randomized studies analyzed this subject [81] [82] [83] [84] 85 ] and again the results were heterogeneous. The duration of mechanical ventilation diminished in three out of the five studies, with no differences being observed in two. The length of ICU stay was reduced in two and did not differ in the other two. The mortality was reduced in one of the three studies in which this was analyzed and the incidence of VAP only fell in one of the four studies analyzing this endpoint (Table 2 ). This variability may be due to a lack of homogeneity in regard to the type of population and the temporal definition of early tracheostomy. With respect to VAP the diagnostic criteria used also differed. In two studies quantitative microbiologic cultures were not used [81, 83] and in those using clinical manifestations together with quantitative culture one observed a reduction in the incidence of VAP [84] and the other did not [85 ] .
A recent meta-analysis concluded that early tracheostomy achieves a reduction in the duration of mechanical ventilation and ICU stay but does not modify either the mortality or the risk of VAP [86 ] .
Conclusion
The presence of ETT is currently unavoidable in most patients undergoing mechanical ventilation and its presence as a foreign endocorporal body participates in the appearance of VAP. The ETT eliminates some of the natural defense mechanisms of the airway and provides a vehicle through which the microorganisms may pass to the interior of the lung by the entry of subglottic secretions or the formation of biofilm on the surface of the ETT. The accumulation and posterior entry of contaminated subglottic secretions into the lung seems to have a relevant role in the pathogenesis of VAP. Thus, subglottic aspiration may be an effective measure of prevention. Selective decontamination or more exhaustive than usual control of P cuff have not, to date, demonstrated evident benefits. The causal association between VAP and the biofilm of the ETT has not been strongly established, although, in any case, the biofilm would act as a reservoir of bacteria. The measures tested to treat the biofilm have been able to reduce or eliminate their presence but have not as yet proven to be effective in avoiding VAP. The substitution of the ETT by tracheostomy does not seem to be an effective measure to diminish the incidence of VAP. To date, the actions studied with respect to the ETT have not been able to counteract the deleterious effects of this device as a factor favoring VAP but the advances achieved indicate a more favorable future.
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